Truvian Sciences Accelerates Plans With $27.1 Million Series B Financing to Develop an Automated Benchtop Blood Testing System for Rapid Assessment of a Full Suite of Health Tests

VIEW ARTICLE
If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.